[Interventional revascularization for cardiovascular disease in patients with chronic kidney disease].

Hideki Ishii, Toyoaki Murohara

研究成果: Review article査読

抄録

Chronic kidney disease (CKD) is an independent risk factor for cardiac mortality. Accelerated atherosclerosis is frequently seen in patients with CKD. However, even in drug eluting stent era, higher restenosis rate after percutaneous coronary intervention (PCI) for coronary artery disease remains a clinical limitation in patients with CKD. Similar tendency is also seen when treated with endovascular therapy (EVT) for peripheral artery disease. Thus, management for atherosclerotic disease is very difficult in patients with CKD. Recent reports have shown that improvement of devices and/or intensive medical treatment may contribute better clinical outcomes after PCI or EVT in patients with CKD. In addition, inflammatory markers such as C-reactive protein may predict worse clinical outcomes including restenosis in such population.

本文言語English
ページ(範囲)339-342
ページ数4
ジャーナルNippon rinsho. Japanese journal of clinical medicine
69
2
出版ステータスPublished - 01-02-2011
外部発表はい

All Science Journal Classification (ASJC) codes

  • 医学(全般)

フィンガープリント

「[Interventional revascularization for cardiovascular disease in patients with chronic kidney disease].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル